APA (7th ed.) Citation

Minhye Kim, Ji Min Na, Gyeong-Won Lee, Seung Jun Lee, Jong Duk Kim, & Jung Wook Yang. (2021). EGFR-mutated pulmonary adenocarcinoma with concurrent PIK3CA mutation, and with acquired RET fusion and EGFR T790M mutation after afatinib therapy. Korean Society of Pathologists & the Korean Society for Cytopathology.

Chicago Style (17th ed.) Citation

Minhye Kim, Ji Min Na, Gyeong-Won Lee, Seung Jun Lee, Jong Duk Kim, and Jung Wook Yang. EGFR-mutated Pulmonary Adenocarcinoma with Concurrent PIK3CA Mutation, and with Acquired RET Fusion and EGFR T790M Mutation After Afatinib Therapy. Korean Society of Pathologists & the Korean Society for Cytopathology, 2021.

MLA (9th ed.) Citation

Minhye Kim, et al. EGFR-mutated Pulmonary Adenocarcinoma with Concurrent PIK3CA Mutation, and with Acquired RET Fusion and EGFR T790M Mutation After Afatinib Therapy. Korean Society of Pathologists & the Korean Society for Cytopathology, 2021.